Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Danielle E Harlow"'
Autor:
Ann D Bass, Joshua Katz, Edward Fox, Derrick Robertson, Danielle E. Harlow, Jacob A. Sloane, Brooke Hayward, Augusto Miravalle, Lori A Lebson
Publikováno v:
Neurodegenerative Disease Management. 11:99-111
Cladribine tablets 10 mg (3.5 mg/kg cumulative dose over 2 years) are approved for the treatment of relapsing forms of multiple sclerosis (MS), including relapsing-remitting MS and active secondary progressive MS. However, real-world data on cladribi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d920c53ff76149a3f750fa9e1c954ad1
https://doi.org/10.2217/nmt-2020-0059
https://doi.org/10.2217/nmt-2020-0059
Publikováno v:
Frontiers in Neurology, Vol 6 (2015)
Multiple Sclerosis (MS) is an immune-mediated disorder of the central nervous system that results in destruction of the myelin sheath that surrounds axons and eventual neurodegeneration. Current treatments approved for the treatment of relapsing form
Externí odkaz:
https://doaj.org/article/60e628dc17bd456d83c107b679ac9fc5
Autor:
Jacqueline A Nicholas, Natalie C Edwards, Roger A Edwards, Anna Dellarole, Luigi Manca, Danielle E Harlow, Amy L Phillips
Publikováno v:
Multiple sclerosis journal - experimental, translational and clinical. 8(2)
Background Increased understanding of adherence may facilitate optimal targeting of interventions. Objective To utilize group-based trajectory modeling (GBTM) to understand longitudinal patterns of adherence and factors associated with non-adherence
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d6a6eee1ee2ca55099b27e5e8e87830
https://pubmed.ncbi.nlm.nih.gov/35795102
https://pubmed.ncbi.nlm.nih.gov/35795102
Autor:
Jared T. Ahrendsen, Wendy B. Macklin, Jennifer N. Bourne, Lisbet T. Finseth, Sean P. Hickey, Cecilia M. Culp, Elizabeth Gould, Danielle E. Harlow
Publikováno v:
The Journal of Neuroscience. 38:787-802
Shp2 is a nonreceptor protein tyrosine phosphatase that has been shown to influence neurogenesis, oligodendrogenesis, and oligodendrocyte differentiation. Furthermore, Shp2 is a known regulator of the Akt/mammalian target of rapamycin and ERK signali
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17d52cdd52c9f7842d507887fc341fc4
https://doi.org/10.1523/jneurosci.2864-16.2017
https://doi.org/10.1523/jneurosci.2864-16.2017
Autor:
Yiting Liu, Wendy B. Macklin, Katherine S. Given, Danielle E. Harlow, Gregory P. Owens, Jeffrey Bennett, Adeline M. Matschulat
Publikováno v:
Acta Neuropathologica Communications
Intrathecal immunoglobulin G (IgG) synthesis, cerebrospinal fluid (CSF) oligoclonal IgG bands and lesional IgG deposition are seminal features of multiple sclerosis (MS) disease pathology. Both the specific targets and pathogenic effects of MS antibo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59b22742f28ca1556341155b33a9b06a
https://pubmed.ncbi.nlm.nih.gov/28340598
https://pubmed.ncbi.nlm.nih.gov/28340598
Publikováno v:
The Journal of Neuroscience. 34:1333-1343
Plp1gene expression occurs very early in development, well before the onset of myelination, creating a conundrum with regard to the function of myelin proteolipid protein (PLP), one of the major proteins in compact myelin. Using PLP-EGFP mice to inve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3280c0307098704cb60030b32c929064
https://doi.org/10.1523/jneurosci.2477-13.2014
https://doi.org/10.1523/jneurosci.2477-13.2014
Autor:
Yiting Liu, Katherine S. Given, Wendy B. Macklin, Danielle E. Harlow, Jeffrey Bennett, Gregory P. Owens
Publikováno v:
Journal of Neuroinflammation
Background Studies of neuromyelitis optica (NMO), an autoimmune disease of the central nervous system (CNS), have demonstrated that autoantibodies against the water channel aquaporin-4 (AQP4) induce astrocyte damage through complement-dependent cytot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ffb4e20a48b8cdc4c12fabef1fc468cf
http://europepmc.org/articles/PMC5134246
http://europepmc.org/articles/PMC5134246
Autor:
Danielle E. Harlow, R.A. Edwards, L. Manca, A. Dellarole, Amy L. Phillips, N.C. Edwards, J. Nicholas
Publikováno v:
Value in Health. 22:S43
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2be850d5ceda655cd203d38f33e6d22d
https://doi.org/10.1016/j.jval.2019.04.061
https://doi.org/10.1016/j.jval.2019.04.061
Autor:
Danielle E. Harlow, N.C. Edwards, J. Nicholas, Amy L. Phillips, A. Dellarole, R.A. Edwards, L. Manca
Publikováno v:
Value in Health. 22:S287
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d7524d6c48bc21d575115a146c986491
https://doi.org/10.1016/j.jval.2019.04.1364
https://doi.org/10.1016/j.jval.2019.04.1364
Publikováno v:
Frontiers in Neurology
Frontiers in Neurology, Vol 6 (2015)
Frontiers in Neurology, Vol 6 (2015)
Multiple Sclerosis (MS) is an immune-mediated disorder of the central nervous system that results in destruction of the myelin sheath that surrounds axons and eventual neurodegeneration. Current treatments approved for the treatment of relapsing form
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df03dabab9c0ec78d6b8a9668c756676